ITEK stock pitch - 2017-08-22

Added to YB: 2017-08-22

Pitch date: 2017-08-22

Inotek Pharmaceuticals Corporation

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

As of January 4, 2018, Inotek Pharmaceuticals Corporation was acquired by Rocket Pharmaceuticals, Ltd.

Market Cap

$82.8M

Pitch Price

$10.80

Price Target

N/A

Dividend

N/A

EV/EBITDA

N/A

P/E

-2.79

EV/Sales

N/A

Sector

Biotechnology

A summary for this pitch has not been created yet.